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phleboviruses, which are closely re-
lated to SFTSV and HLV, may be 
more generally distributed in the 
midwestern United States and em-
phasizes the need to substantiate our 
serologic evidence with virus isolation 
and genomic characterization, which 
are underway.
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Infectious  
Schmallenberg  
Virus from Bovine 
Semen, Germany
To the Editor: The teratogenic 
Schmallenberg virus (SBV) (genus 
Orthobunyavirus) was detected in 
bovine semen in a recent German 
field study (1). Vector-borne trans-
mission by Culicoides spp. biting 
midges is most common (2), but ve-
nereal transmission of SBV might 
contribute to the spread of this virus 
to previously unaffected regions. We 
investigated the infectivity of SBV 
RNA–positive semen by experimen-
tal subcutaneous injection of cattle 
and interferon α/β receptor–deficient 
(IFNAR-/-) mice (3).
Commercially produced semen 
straws with egg yolk–based diluent 
were used for the injection of 6- to 
9-month-old heifers. The straws origi-
nated from 6 semen batches (quanti-
fication cycle [C
q
] values 26.4–36.4) 
collected from 6 bulls (designated 
A–C and E–G) during August and 
September 2012 (1). To increase the 
probability of SBV infection of inject-
ed cattle, 5 straws of semen (≈220 µL 
each) from 1 batch from an individual 
bull were pooled and diluted in mini-
mal essential medium with antibiotics 
to 4 mL. Six cattle (C1–6) were subcu-
taneously inoculated, each with a pool 
from 1 of the 6 bulls. To investigate 
the infectivity of a single insemination 
dose (1 straw), 5 cattle (C7–C11) were 
subcutaneously injected with single 
straws from bull F that had been con-
firmed to contain infectious SBV. Se-
rum samples were obtained on several 
days (Figure), and clinical signs and 
rectal body temperatures for the in-
jected cattle were monitored daily.
In addition, 20 SBV RNA–posi-
tive semen batches (C
q
 25.9 to 36.5) 
collected from 11 bulls (A–K) during 
August–November 2012 (1) were sub-
cutaneously injected into 40 IFNAR-/- 
mice (4–6 weeks old). For each batch, 
2 mice were each injected with half 
of a semen straw (80–120 µL). All 
mice were monitored clinically and 
weighed daily. Samples of serum, 
liver, and spleen were harvested im-
mediately after euthanasia at 22 days 
postinjection (dpi).
All serum samples and organ 
homogenates were tested for SBV 
RNA by using small segment–specific 
quantitative reverse transcription PCR 
(4). Serum samples were tested for 
SBV-specific antibodies by using the 
ID Screen Schmallenberg Virus Com-
petition ELISA (IDvet, Montpellier, 
France), according to the manufactur-
er’s instructions; selected serum sam-
ples were also tested by neutralization 
test against an original SBV isolate 
from Germany, as described (5).
SBV infection was confirmed in 5 
of 11 injected cattle: C3, C5, and C9–
C11. SBV RNA (C
q
 25.0–29.3) was 
first detected in serum at 3 to 6 dpi and 
persisted for 2–4 days. Seroconversion 
occurred at 8–12 dpi (Figure). None 
of the SBV-infected animals showed 
obvious clinical signs or fever; this 
finding is in accordance with reports 
of subclinical SBV infection in adult 
cattle (5–7). Samples from the other 6 
cattle and all IFNAR-/- mice had nega-
tive results (data not shown).
The 2 infectious semen batches 
contained moderate (C
q
 26.4) or low 
(C
q
 34.2) viral loads of SBV RNA, 
indicating that a high sensitivity is 
required for reliable SBV RNA de-
tection in semen samples (1). The on-
set of SBV infection in the 3 animals 
injected with single semen straws 
ranged from 3 to 5 dpi, and not ev-
ery straw was infectious, although 
biologic and technical replicates of 
straws from 1 semen batch showed 
similar PCR results (data not shown) 
(1). Possible explanations for differ-
ences in the infectivity of individual 
straws are that the viral RNA load of 
an SBV-containing straw does not 
necessarily correlate with infectiv-
ity or that the infectivity of 1 straw 
is lower than the minimal cattle 
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infectious dose for SBV. Cattle might 
be more susceptible than IFNAR-/- 
mice to infection, particularly when 
SBV titers are low or borderline (7, 
8). Therefore, we cannot exclude the 
possibility that the semen batches 
tested only in IFNAR-/- mice might 
be infectious for cattle or that semen 
samples with higher SBV titers might 
be infectious in the mice.
We used subcutaneous injec-
tion of SBV RNA–positive semen 
to demonstrate infectivity because 
this transmission route has a high 
sensitivity for proving infectivity of 
SBV-containing samples (7). Howev-
er, the possibility of intrauterine SBV 
infection of dams is unknown. Oro-
nasal inoculation of 2 calves did not 
result in SBV infection of the animals 
(5), which suggests that mucosal in 
utero infection with SBV-containing 
semen is unlikely. In contrast, vire-
mia was detected in most cows that 
were artificially inseminated and si-
multaneously inoculated in the uterus 
with cell culture–passaged Akabane 
virus, a teratogenic orthobunyavirus 
closely related to SBV (9). Intrauter-
ine lesions caused by insemination or 
breeding might therefore increase the 
risk for SBV infection.
In conclusion, we demonstrated 
that SBV RNA–positive bovine semen 
could contain infectious SBV. How-
ever, the actual risk for transmission 
of SBV by insemination of dams with 
SBV-containing semen remains to be 
evaluated. Although SBV infection of 
the developing embryo is unlikely, ve-
nereal transmission would lead at worst 
to viremia of the dam, facilitating vec-
tor transmission. To prevent venereal 
SBV transmission, sensitive PCR test-
ing of semen batches from SBV-infect-
ed bulls is the method of choice (1,10).
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Figure.	Detection	of	Schmallenberg	virus	(SBV)	RNA	and	antibodies	in	serum	of	5	of	11	
cattle	(C)	injected	with	SBV	RNA–positive	bovine	semen	(quantification	cycle	[Cq]	values	
26.4–36.4).	Infectivity	was	measured	by	using	reverse	transcription	PCR	(Cq),	competitive	
ELISA	(%	negative	control),	and	serum	neutralization	test	(ND50,	serum	dilution	that	caused	
virus	neutralization	 in	50%	of	 the	 replicates).	RNAemia	and	seroconversion	occurred	 in	
C3,	injected	with	pooled	semen	from	bull	C	(Cq	34.2),	and	in	C5	and	C9–C11,	injected	with	
pooled	or	single	semen	straws	from	bull	F	(Cq	26.4).	The	onset	of	infection	in	cattle	injected	
with	semen	 from	bull	F	varied	between	3	and	5	days	postinfection.	Black	 lines	 indicate	
virologic	 and	 serologic	 results	 for	 cattle	 that	 remained	 uninfected.	Dotted	 lines	 indicate	
positive	(top)	and	negative	(bottom)	cutoff	values;	whiskers	indicate	SD	of	the	mean.
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NDM-1–producing 
Strains, Family  
Enterobacteriaceae, 
in Hospital,  
Beijing, China
To the Editor: The prevalence 
of New Delhi metallo-b-lactamase-1 
(NDM-1)–producing strains (fam-
ily Enterobacteriaceae) in China re-
mains unclear. Recently, to clarify 
the prevalence of blaNDM-1 in Entero-
bacteriaceae strains, we carried out 
retrospective surveillance for blaNDM-1 
among carbapenem-resistant entero-
bacterial strains isolated from patients 
at the Chinese PLA General Hospital 
in Beijing. This tertiary teaching hos-
pital has 4,000 beds and 12,000 daily 
outpatient visits. More than 50% of 
patients admitted to the hospital are 
from areas outside Beijing. During 
January 2009–June 2013, a total of 
8,586 enterobacterial isolates were 
obtained from routine clinical samples 
that had been passively sent to the 
microbiology department. Of these, 
242 (2.8%) strains exhibited resis-
tance to carbapenems. 
In this study, we used PCR am-
plification to screen the carbapenem-
resistant strains for the blaNDM-1 gene 
and other common resistance deter-
minants. The MICs of various antimi-
crobial drugs were measured by E-test 
(AB bioMérieux, Solna, Sweden). 
S1 nuclease pulsed-field gel electro-
phoresis and Southern blot analysis 
were used to identify the sizes of 
blaNDM-1-carrying plasmids. The in-
compatibility (Inc) groups of the 
plasmids were detected by several 
multiplex and simplex PCRs. Multi-
locus sequence typing (MLST) was 
carried out for Klebsiella pneumoniae 
and Escherichia coli isolates, accord-
ing to protocols provided on MLST 
websites (www.pasteur.fr/recherche/
genopole/PF8/mlst/Kpneumoniae.html 
and http://mlst.ucc.ie/mlst/dbs/Ecoli). 
The transferability of plasmids was 
identified by conjugation experiments.
Five blaNDM-1-positive enterobac-
terial isolates of the following species 
were identified: E. coli (1 isolate in Oc-
tober2010), K. pneumoniae (1 isolate 
in August 2012), Providencia rettgeri 
(1 isolate in October 2012), Entero-
bacter cloacae (1 isolate in November 
2012), and Raoultella ornithinolytica 
(1 isolate in March 2013). Accord-
ing to the 2013 Clinical and Labora-
tory Standards Institute  performance 
standard M100-S23 (www.clsi.org/), 
the NDM-1-producing K. pneumoniae 
(IR5047) isolate exhibited low-level 
resistance to imipenem and merope-
nem, whereas other isolates showed 
high-level resistance to carbapenems. 
Only E. coli and Providencia rettgeri, 
which carry 16S rRNA methylase 
genes, exhibited high-level resistance 
to amikacin (Table). S1 nuclease 
pulsed-field gel electrophoresis and 
Southern blot analysis showed that the 
blaNDM-1 gene was located on plasmids 
of various sizes belonging to different 
Inc groups. The K. pneumoniae isolate 
was defined as a novel ST1240 with 
the allelic profile 2–1-1–1-1–3-24, 
and the E. coli isolate was identified 
as ST167.
In China, various blaNDM-1-carry-
ing strains of the Enterobacteriaceae 
have been sporadically identified, in-
cluding K. pneumoniae, K. oxytoca, 
Escherichia coli, Enterobacter cloa-
cae, Enterobacter aerogenes, and 
Citrobacter freundii (1–4). We iden-
tified a P. rettgeri isolate and an R. 
ornithinolytica isolate that produced 
NDM-1. The blaNDM-1-positive P. 
rettgeri isolates have also been iden-
tified in Pakistan, India, Canada, and 
Mexico, whereas the NDM-1-pro-
ducing R. ornithinolytica strain has 
only been detected in India (5–9). 
In this study, all 5 NDM-1–produc-
ing strains were isolated only once, 
and no dissemination of NDM-1–
producing strains of Enterobacteria-
ceae has been found. Two strains (K. 
pneumoniae and Enterobacter cloa-
cae) were isolated within 48 hours 
of the patient’s hospital admission, 
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